Climb Bio, Inc. — Form D

Climb Bio, Inc. of WELLESLEY HILLS, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-28. The offering totals $60.0M, of which $60.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Robert AzelbyDirectorRedmond, WA
Leone PattersonDirectorRedmond, WA
Robert AzelbyExecutive OfficerRedmond, WA
James BucherExecutive OfficerRedmond, WA
Erin LavelleExecutive OfficerCharlottesville, VA
Andrew LevinDirectorBOSTON, MA
Andrew LevinExecutive OfficerBOSTON, MA
Andrew LevinRelated PersonBOSTON, MA
Stephen ThomasDirectorDallas, TX
Stephen ThomasRelated PersonDallas, TX
Julio VegaExecutive OfficerCambridge, MA
Liam RatcliffeDirectorNew York, NY
Adam RosenbergDirectorWilmington, DE
Simon TateDirectorWilmington, DE
Aoife BrennanDirectorWellesley Hills, MA
Aoife BrennanExecutive OfficerWellesley Hills, MA
Aoife BrennanRelated PersonWellesley Hills, MA
Judith DunnDirectorWellesley Hills, MA
Judith DunnRelated PersonWellesley Hills, MA
Valerie MorissetExecutive OfficerWilmington, DE
David-Alexandre GrosDirectorIrvine, CA
Douglas WilliamsRelated PersonWellesley Hills, MA
Harald StockDirectorPark City, UT
Susan AltschullerRelated PersonWellesley Hills, MA
Perrin WilsonRelated PersonWellesley Hills, MA

Other filings by this issuer (7)

FiledFormOfferingSold
2026-05-04D$110.1M$110.1M
2024-07-02D$120.0M$120.0M
2024-07-02D$41.9M$41.9M
2020-11-03D$50.0M$5.0M
2019-10-23D$10.0M$10.0M
2019-10-23D/A$16.3M$16.3M
2019-02-19D$12.2M$12.2M

More